Baird Medical Investment Stock Probability Of Bankruptcy
BDMD Stock | 1.76 0.01 0.57% |
Baird |
Baird Medical Investment Company probability of distress Analysis
Baird Medical's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Baird Medical Probability Of Bankruptcy | Less than 9% |
Most of Baird Medical's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Baird Medical Investment is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Baird Medical probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Baird Medical odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Baird Medical Investment financial health.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baird Medical. If investors know Baird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baird Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Baird Medical Investment is measured differently than its book value, which is the value of Baird that is recorded on the company's balance sheet. Investors also form their own opinion of Baird Medical's value that differs from its market value or its book value, called intrinsic value, which is Baird Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baird Medical's market value can be influenced by many factors that don't directly affect Baird Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baird Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baird Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baird Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Baird Probability Of Bankruptcy Driver Correlations
Understanding the fundamental principles of building solid financial models for Baird Medical is extremely important. It helps to project a fair market value of Baird Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Baird Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Baird Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Baird Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition |
Based on the latest financial disclosure, Baird Medical Investment has a Probability Of Bankruptcy of 9.0%. This is 79.21% lower than that of the Healthcare sector and 78.14% lower than that of the Medical Devices industry. The probability of bankruptcy for all United States stocks is 77.4% higher than that of the company.
Baird Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Baird Medical's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Baird Medical could also be used in its relative valuation, which is a method of valuing Baird Medical by comparing valuation metrics of similar companies.Baird Medical is currently under evaluation in probability of bankruptcy category among its peers.
About Baird Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Baird Medical Investment's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Baird Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Baird Medical Investment based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Baird Medical Investment is a strong investment it is important to analyze Baird Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Baird Medical's future performance. For an informed investment choice regarding Baird Stock, refer to the following important reports:Check out Baird Medical Piotroski F Score and Baird Medical Altman Z Score analysis. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baird Medical. If investors know Baird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baird Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Baird Medical Investment is measured differently than its book value, which is the value of Baird that is recorded on the company's balance sheet. Investors also form their own opinion of Baird Medical's value that differs from its market value or its book value, called intrinsic value, which is Baird Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baird Medical's market value can be influenced by many factors that don't directly affect Baird Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baird Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baird Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baird Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.